Carcinoma, Non-Small-Cell Lung — Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Citation(s)
A Phase II Trial of Pemetrexed (Alimta [Registered Trademark]) Combined With Sirolimus (Rapamycin, Rapamune [Registered Trademark]) in Subjects With Relapsed or Refractory NSCLC